0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Viewpoint |

Focusing PSA Testing on Detection of High-Risk Prostate Cancers by Incorporating Patient Preferences Into Decision Making

Ian M. Thompson Jr, MD1; Robin J. Leach, PhD1; Donna P. Ankerst, PhD1,2,3
[+] Author Affiliations
1Department of Urology and Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio
2Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio
3Department of Mathematics, Technical University Munich, Germany
JAMA. 2014;312(10):995-996. doi:10.1001/jama.2014.9680.
Text Size: A A A
Published online

Extract

In the mid-1980s, the discovery that prostate-specific antigen (PSA) testing, coupled with prostate biopsy, could identify silent prostate cancers that would otherwise be present as metastatic disease led to substantial increases in cancer detection and subsequent treatment. With time, more intensive screening and biopsy led to significant increases in detection of low-grade tumors that are almost ubiquitous at autopsy in older men. Although during the ensuing 2 decades there was a 44% decline in prostate cancer mortality (likely attributable, in part, to early detection with PSA testing), the effect of detection and treatment as well as the complications from treatment (erectile dysfunction, urinary obstruction or incontinence, and gastrointestinal adverse effects) led the US Preventive Services Task Force to recommend against PSA screening in the general population.1 Results from 2 large randomized clinical trials (RCTs) of PSA screening, in which a European RCT reported a modest reduction in prostate cancer mortality and a US trial found no change in mortality, reinforced this conclusion.2,3

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Multimedia

Author Reading

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

Users' Guides to the Medical Literature
Chapter 22.2. Decision Making and the Patient

Users' Guides to the Medical Literature
The Role of Costs in Clinical Decision Making Remains Controversial

brightcove.createExperiences();